C-reactive protein predicts vascular access thrombosis in hemodialysis patients

Blood Purification

Volumn 24, Issue 4, 2006, Pages 342-346

  Chou, Che Yi ^a   Kuo, Huey Liang ^a   Yung, Ya Fei ^a   Liu, Yao Lung ^a   Huang, Chiu Ching ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

C reactive protein; Hemodialysis; Stenosis; Thrombosis; Vascular access

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; C REACTIVE PROTEIN; CALCIUM PHOSPHATE; CHOLESTEROL; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PARATHYROID HORMONE; SERUM ALBUMIN; SIMVASTATIN; WARFARIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; FEMALE; FOREARM; GENDER; GROUPS BY AGE; HEMATOCRIT; HEMODIALYSIS PATIENT; HUMAN; KAPLAN MEIER METHOD; KIDNEY ARTERIOVENOUS FISTULA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SERUM; SMOKING; STATISTICAL ANALYSIS; SURVIVAL; THROMBOSIS; VASCULAR ACCESS; VASCULAR ACCESS THROMBOSIS;

AGED; ARTERIOVENOUS SHUNT, SURGICAL; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBOSIS;

EID: 33747062712     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092558     Document Type: Article

References (16)

1. Feldman HI, Kobrin S, Wasserman A: Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996;7:523-535.
2. de Graaf R, Dammers R, Vainas T, Hoeks AP, Tordoir JH: Detection of cell-cycle regulators in failed arteriovenous fistulas for haemodialysis. Nephrol Dial Transplant 2003;18:814-818.
3. Schillinger M, Exner M, Sabeti S, Amighi J, Wagner O, Ahmadi R, Minar E: Excessive carotid in-stent neointimal formation predicts late cardiovascular events. J Endovasc Ther 2004;11:229-239.
4. Hashimoto H, Kitagawa K, Hougaku H, Etani H, Hori M: Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects. Stroke 2004;35:1625-1630.
5. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK.Konner K: Increasing the proportion of diabetics with AV fistulas. Semin Dial 2001;14:1-4.
6. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK: Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 2001;60:1443-1451.
7. Fernandez-Andrade C: Renal markers and predictors, and renal and cardiovascular risk factors. Nefrologia 2002;22(suppl 1):2-29.
8. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000;35:469-476.
9. Weiss MF, Scivittaro V, Anderson JM: Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis 2001;37:970-980.
10. Lemson MS, Tordoir JH, Daemen MJ, Kitslaar PJ: Intimal hyperplasia in vascular grafts. Eur J Vasc Endovasc Surg 2000;19:336-350.
11. Windus DW: Permanent vascular access: a nephrologist's view. Am J Kidney Dis 1993;21:457-471.
12. Jabs WJ, Theissing E, Nitschke M, Bechtel JF, Duchrow M, Mohamed S, Jahrbeck B, Sievers HH, Steinhoff J, Bartels C: Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation 2003;108:1428-1431.
13. Schillinger M, Haumer M, Schlerka G, Mlekusch W, Exner M, Ahmadi R, Minar E: Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation. J Endovasc Ther 2001;8:477-483.
14. Chang CJ, Ko PJ, Hsu LA, Ko YS, Ko YL, Chen CF, Huang CC, Hsu TS, Lee YS, Pang JH: Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis 2004;43:74-84.
15. Doggrell SA: Relating statin therapy to C-reactive protein levels. Expert Opin Pharmacother 2005;6:1597-1600.
16. Miller PE, Carlton D, Deierhoi MH, Redden DT, Allon M: Natural history of arteriovenous grafts in hemodialysis patients. Am J Kidney Dis 2000;36:68-74.